J Breast Cancer.  2019 Sep;22(3):375-386. 10.4048/jbc.2019.22.e43.

In Vitro and In Vivo Study on the Effect of Lysosome-associated Protein Transmembrane 4 Beta on the Progression of Breast Cancer

  • 1Department of Oncological Surgery, Enze Hospital of Taizhou Enze Medical Group, Luqiao, Zhejiang, China.
  • 2The Affiliated People's Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, China.
  • 3Gynecology of Taizhou Enze Medical Center (Group) Enze Hospital, Taizhou, Zhejiang, China.
  • 4Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China. wuxia_imu@163.com


Although the effect of lysosome-associated protein transmembrane 4 beta (LAPTM4B) on the proliferation, migration, and invasion of breast cancer (BC) cells has already been studied, its specific role in BC progression is still elusive. Here, we evaluated the effect of different levels of LAPTM4B expression on the proliferation, invasion, adhesion, and tumor formation abilities of BC cells in vitro, as well as on breast tumor progression in vivo.
We investigated the influence of LAPTM4B expression on MCF-7 cell proliferation, invasion, adhesion, and tube formation abilities in vitro through its overexpression or knockdown and on breast tumor progression in vivo.
Cell growth curves and colony formation assays showed that LAPTM4B promoted the proliferation of breast tumor cells. Cell cycle analysis results revealed that LAPTM4B promoted the entry of cells from the G1 into the S phase. Transwell invasion and cell extracellular matrix adhesion assays showed that LAPTM4B overexpression increased the invasion and adhesion capabilities of MCF-7 cells. More branches were observed in MCF-7 cells overexpressing LAPTM4B under an electron microscope. In comparison with LAPTM4B overexpression, LAPTM4B knockdown decreased the expression of vascular endothelial growth factor-A and significantly inhibited the vasculogenic tube formation ability of tumors. These results were also verified with western blot analysis.
LAPTM4B promoted the proliferation of MCF-7 cells through the downregulation of p21 (WAF1/CIP1) and caspase-3, and induced cell invasion, adhesion, and angiogenesis through the upregulation of hypoxia-inducible factor 1 alpha, matrix metalloproteinase 2 (MMP2), and MMP9 expression. This specific role deems LAPTM4B as a potential therapeutic target for BC treatment.


Breast neoplasms; Disease progression; LAPTM4B protein, human; MCF-7 cells

MeSH Terms

Blotting, Western
Breast Neoplasms*
Caspase 3
Cell Cycle
Disease Progression
Extracellular Matrix
Hypoxia-Inducible Factor 1
In Vitro Techniques*
Matrix Metalloproteinase 2
MCF-7 Cells
S Phase
Vascular Endothelial Growth Factor A
Caspase 3
Hypoxia-Inducible Factor 1
Matrix Metalloproteinase 2
Vascular Endothelial Growth Factor A
Full Text Links
  • JBC
export Copy
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error